Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale
Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Ashley Kieran Clift
,
Nadja Auerbach
,
Vivian N. Liu
,
Hans Johnson
,
Thomas Curtis
,
David R. Huang
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Diabetes, Obesity and Metabolism
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.16375
Similar Items
Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety
by: Hans Johnson, et al.
Published: (2025)
Predicting 10‐year risk of type 2 diabetes in Chinese people with overweight or obesity treated with Tirzepatide: Post hoc analysis of SURMOUNT ‐ CN trial
by: Lin Zhao, et al.
Published: (2025)
Tirzepatide and health‐related quality of life in adults with obesity or overweight: Results from the SURMOUNT ‐3 phase 3 randomized trial
by: Theresa Hunter Gibble, et al.
Published: (2025)
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
by: Emily R. Hankosky, et al.
Published: (2025)
Interpreting Post‐Discontinuation Trajectories After Semaglutide or Tirzepatide
by: Man Sun, et al.
Published: (2026)